Format

Send to:

Choose Destination

Links from GEO Profiles

Full record GDS5815

Sunitinib effect on renal cancer xenograft tumors

Analysis of Kyoto University Renal Cancer (KURC) xenograft tumor models, KURC1, KURC2, KURC3, treated with sunitinib, a small molecule inhibitor of receptor tyrosine kinases that is used to treat RC. Results provide insight into molecular mechanisms underlying acquired sunitinib resistance in RC.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 agent, 3 disease state, 3 individual sets
Platform:
GPL6244
Series:
GSE66346
9 Samples
Download data: CEL

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center